Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

92.77 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

59 60 Next >

WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake ↗

May 19, 2023

An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the

Via Benzinga

DeSantis Vs. Disney, Alibaba Spinoffs Cloud Business, Apple Bans Internal ChatGPT Use: Today's Top Stories ↗

May 19, 2023

Bloomberg

Via Benzinga

AstraZeneca's China Executive Seeks Loyalty to "Love the Communist Party" In China ↗

May 19, 2023

During an event held in the city of Wuxi to commemorate its 30th year in China, AstraZeneca Plc's (NASDAQ: AZN) China president, Wang Lei, said the company will seek to be a patriotic company in China...

Via Benzinga

The 7 Next Trillion-Dollar Companies to Invest in Now ↗

May 18, 2023

These are the next trillion-dollar companies to buy thanks to visibility, steady revenue growth and cash flow upside.

Via InvestorPlace

Is AstraZeneca Stock a Buy for Growth Investors? ↗

May 14, 2023

This drugmaker is among the largest international players in the world.

Via The Motley Fool

AstraZeneca Unusual Options Activity ↗

May 12, 2023

Via Benzinga

Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories ↗

May 17, 2023

Benzinga

Via Benzinga

One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps ↗

May 17, 2023

AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...

Via Benzinga

AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer ↗

May 17, 2023

AstraZeneca Plc (NASDAQ: AZN) has reported topline data

Via Benzinga

Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody ↗

May 12, 2023

The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have

Via Benzinga

What Does AstraZeneca's Debt Look Like? ↗

May 09, 2023

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today ↗

May 03, 2023

Via Benzinga

AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript ↗

April 28, 2023

AZN earnings call for the period ending March 31, 2023.

Via The Motley Fool

Earnings Outlook For AstraZeneca ↗

April 26, 2023

Via Benzinga

Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns ↗

May 12, 2023

The monoclonal antibody shot significantly reduced the risk of hospitalization in babies.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2023

Via Benzinga

How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports ↗

May 09, 2023

Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street.

Via Benzinga

Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance ↗

May 09, 2023

Via Benzinga

A Look Into AstraZeneca's Debt ↗

April 19, 2023

Via Benzinga

The 7 Best Mutual Funds to Invest in for May 2023 ↗

May 08, 2023

With rising uncertainties in the economy and the capital markets, investors have an incentive to consider the best mutual funds.

Via InvestorPlace

WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns ↗

May 08, 2023

The World Health Organization ended the global emergency

Via Benzinga

GSK: Add This Cheap Chip Play To Your Portfolio ↗

May 06, 2023

GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%.

Via Talk Markets

3 Low-Volatility Stocks for a Stable Investment Strategy ↗

May 06, 2023

These are the low-volatility stocks to buy for high total returns as they represent attractively-valued dividend names.

Via InvestorPlace

FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug ↗

May 01, 2023

Via Benzinga

FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting ↗

April 27, 2023

The FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss the supplemental new drug application (sNDA) for Lynparza (olaparib) in combination with abiraterone...

Via Benzinga

AstraZeneca's COVID-19 Vaccine Loses Shine, Cancer Drug Imfinzi & Emerging Markets Stabilize Q1 Revenues ↗

April 27, 2023

AstraZeneca Plc (NASDAQ: AZN) has reported Q1 FY23 core EPS of $1.92, up 1% Y/Y (+6% on constant currency), better than the consensus of $1.07. The company clocked Q1 sales of $10.88 billion, -4% (flat...

Via Benzinga

7 Low-Risk Stocks to Buy if You Only Want to Beat Inflation ↗

April 26, 2023

Getting in on some low-risk stocks is a good idea if you want to preserve your capital during inflation and before the upcoming recession.

Via InvestorPlace

Artelo Enters Next Phase Of Evaluation Of Its Cannabinoid Receptor Targeting Drug For The Treatment Of Cancer-Related Anorexia And Weight Loss ↗

April 26, 2023

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and...

Via Benzinga

AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression ↗

April 24, 2023

Via Benzinga

Could This Rare-Disease Drug Candidate Become a Blockbuster? ↗

April 19, 2023

This drug candidate could be a great treatment option for patients with a potentially deadly disease.

Via The Motley Fool

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

Headline News about AstraZeneca PLC - American Depositary Shares

Starting at $3.75/week.

Subscribe Today